Financials
- Market Capitalization 215.32 M
- Employee 152
- Founded 2016
- CEO N/A
- Website www.entradatx.com
- Headquarter Delaware, United States
- FIGI BBG00MTSMC16
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.96
ratio cours/chiffre d'affaires
16.73
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3476 | SION Sionna Therapeutics, Inc. - Common Stock | 4.75 USD | -3.06% | -1.66% | -39.41% | -87.93% | 214.76 M USD | ||
| 3479 | PLX Protalix BioTherapeutics, Inc. Common Stock | 2.78 USD | +0.72% | +3.35% | +6.11% | -4.79% | 223.99 M USD | ||
| 3489 | ADCT ADC Therapeutics SA Common Shares | 1.81 USD | +4.62% | +49.59% | +69.16% | -59.05% | 231.08 M USD | ||
| 3498 | RNAC Cartesian Therapeutics, Inc. - Common Stock | 6.99 USD | -0.99% | -3.59% | -14.65% | -23.69% | 211.48 M USD |